Showing 2211-2220 of 3402 results for "".
How Epidermolysis Bullosa Treatments Went from Blisters to Breakthroughs
https://practicaldermatology.com/topics/rare-disease/how-epidermolysis-bullosa-treatments-went-from-blisters-to-breakthroughs/54391/Current FDA-approved therapies oleogel-S10, beremagene geperpavec, and prademagene zamikeracel represent major therapeutic breakthroughs for the treatment of epidermolysis bullosa (EB). Earlier systemic intervention, improved nutrition, and proactive management of complications have extended survivUpdate on Diagnosis and Topical Management of Erythrasma
https://practicaldermatology.com/topics/general-topics/PD0909_03-php/22767/This under-diagnosed cutaneous infection is caused by a bacterium but may respond to anti-fungal therapies.On Meetings and Efficiency: Dermato-philosophy
https://practicaldermatology.com/topics/practice-management/on-meetings-and-efficiency-dermato-philosophy/23855/Insights into how to maximize meeting efficiency.Basal Cell Carcinoma in Skin of Color: A Case Series
https://practicaldermatology.com/topics/skin-cancer-photoprotection/basal-cell-carcinoma-in-skin-of-color-a-case-series/23814/BCC is not common in patients with skin of color; it tends to have a delayed diagnosis and can have a more serious disease course.The Microbiome in Atopic Dermatitis: Where Are We Now?
https://practicaldermatology.com/topics/atopic-dermatitis/the-microbiome-in-atopic-dermatitis-where-are-we-now/23746/It seems increasingly likely that microbes will play a central role in understanding AD and its treatments.Are Sunscreens and Cosmetics Really Safe?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/are-sunscreens-and-cosmetics-really-safe/23558/There is basis for some of the concern around skincare ingredients, but dermatologists have the knowledge and expertise to guide patients to products that are safe.Sunscreen Ratings, Long Live Skin Launches, SCALE Highlights
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-sunscreen-ratings-long-live-skin-launches-scale-highlights/18471/Consumer Reports says that one-third of sunscreens tested in its latest evaluation provided less than half of the SPF protection touted on the label. For its part, the American Academy of Dermatology is reminding patients that sunscreen ingredients are safe. The Environmental Working Group continuesDermwireTV — Sun Rises, ICD-10 is Delayed…Again
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-sun-rises-icd-10-is-delayed-again/19139/In this week's DermwireTV, Sun acquires Ranbaxy, ICD-10 gets unexpectedly delayed, and Murad Alam recaps the ASLMS conference.Cosmetics Challenge: Going with the Flow: An Overview and Clinical Discussion of The Rheology of Soft Tissue Fillers, Part 1 of 2
https://practicaldermatology.com/topics/general-topics/cosmetics-challenge-going-with-the-flow-an-overview-and-clinical-discussion-of-the-rheology-of-soft-tissue-fillers-part-1-of-2/21890/Flow properties and the clinical behavior that these properties predict can be important factors that help clinicians refine and individualize treatment with dermal fillers.Non-genital Warts: A Review of Current Treatments
https://practicaldermatology.com/topics/general-topics/non-genital-warts-a-review-of-current-treatments/21884/When determining which treatment modality to choose for non-genital warts, there are several factors to consider, including the convenience of the treatment, patient discomfort, location of warts, and potential side effects.